SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001178913-15-003066
Filing Date
2015-10-16
Accepted
2015-10-16 07:00:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3/A zk1517403.htm F-3/A 754008
2 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES exhibit_12-1.htm EX-12.1 60173
3 CONSENT OF KESSELMAN AND KESSELMAN exhibit_23-1.htm EX-23.1 5981
4 biolinerx.jpg GRAPHIC 5680
5 chart2.jpg GRAPHIC 109082
6 pwc.jpg GRAPHIC 3415
  Complete submission text file 0001178913-15-003066.txt   984282
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-205700 | Film No.: 151161063
SIC: 2834 Pharmaceutical Preparations